The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
A new study on HIV and HCV co-infection confirms a significantly greater mortality rate for individuals infected with both viruses than those infected with only one. Researchers also reported that for yet unexplained reasons, white people are twice as likely to die from co-infection than black people.
Continue reading »The recent discovery that the Hepatitis C virus needs a small part of RNA found only in the liver to replicate itself has sparked new treatment approaches. If researchers can determine whether lowering the amount of this RNA decreases viral load without adversely affecting the liver we may see a promising breakthrough.
Continue reading »By overcoming the difficulties of culturing live HCV, scientists are now capable of studying the virus more closely. We anticipate this progress will open the door to hepatitis C treatment and prevention.
Continue reading »An Iranian research study recently concluded that the herbal components of Liv.52 are beneficial in the treatment of cirrhotic patients. The six-month study demonstrated that patients treated with Liv.52 showed better test results than those treated with placebo.
Continue reading »The Hepatitis C Movement for Awareness (HMA) is once again planning a march in Washington DC to promote the need for an awareness campaign. See how you can take part even if you cannot join the march to the White House.
Continue reading »Biologists at Florida State University have recently produced a study illuminating the replication and mutation of the Hepatitis C virus. This kind of progress represents a giant leap forward in tracking this persistent virus, which likely means more accurate and efficient therapy will be coming soon.
Continue reading »A Japanese research study demonstrates benefits of Vitamin E and C supplementation during combination therapy. These vitamins appear to protect cells from damage typically incurred from conventional Hepatitis C therapy.
Continue reading »Schering-Plough's oral HCV protease inhibitor, SCH 503034, is in phase II trials, and may make for a better combination with Peg-intron. Check-in with us regularly, as we will be keeping close tabs on this development.
Continue reading »A May 2005 review of clinical studies which casts doubt on milk thistle’s value has recently been re-released into the... View Article
Continue reading »The start of the New Year was accompanied by the European Patent Office granting a patent for a rapid HCV test. Now that the technology is here, let's hope the test proves accurate, with high levels of selectivity and specificity.
Continue reading »Inside you'll discover:
You'll also receive the latest news and information to support liver health.
Rest assured, we will not rent your email to anyone.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window
